ALLO
ALLOGENE THERAP (ALLO)
NASDAQ
$1.78-$0.004 (-0.22%)
Price as of Sep 11, 2026 7:53 PM EDT
  • $615.0M
    Market Cap
  • 57.52%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 48
Valuation
ALLO
vs History
vs S&P 500
Profitability
-1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 53
Valuation
ALLO
vs History
vs S&P 500
3-Month Momentum
13.74%
12-Month Momentum
76.92%
3-Month Risk Adjusted Momentum
57.00%
12-Month Risk Adjusted Momentum
92.72%

True Yield

N/A
Valuation
ALLO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.0006%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
ALLO
vs History
vs S&P 500
Ohlson's O-Score
5